Finance

Lists
RHY:ASX
Rhythm Biosciences Ltd
A$0.087
+2.35%
(+0.0020) 1D
Sep 4, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RHY...
Open
A$0.09
High
A$0.09
Low
A$0.08
Mkt. cap
30.79M
Avg. vol.
221.22K
Volume
92.76K
52-wk high
A$0.28
52-wk low
A$0.08
EPS
-A$0.02
Shares outstanding
364.06M
Open
A$0.09
High
A$0.09
Low
A$0.08
Mkt. cap
30.79M
Avg. vol.
221.22K
Volume
92.76K
52-wk high
A$0.28
52-wk low
A$0.08
EPS
-A$0.02
Shares outstanding
364.06M
About Rhythm Biosciences Ltd
CEOTrevor Lockett
Employees-
Founded2017
Headquarters-
SectorHealth care provider
Websiterhythmbio.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
811.07K
811.07K
59.29K
59.29K
Cost of goods sold
385.44K
385.44K
-179.08K
-179.08K
Cost of revenue
385.44K
385.44K
-179.08K
-179.08K
Research and development expenses
-
-
519.97K
519.97K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.49M
1.49M
1.49M
1.49M
Operating expense
1.53M
1.53M
2.06M
2.06M
Total operating expenses
1.92M
1.92M
1.88M
1.88M
Operating income
-1.11M
-1.11M
-1.82M
-1.82M
Other non operating income
-
-
-
-
EBT including unusual items
-1.13M
-1.13M
-1.84M
-1.84M
EBT excluding unusual items
-1.13M
-1.13M
-1.84M
-1.84M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.13M
-1.13M
-1.84M
-1.84M
Net profit margin
-139.15%
-139.15%
-3,097.39%
-3,097.39%
Earnings per share
-
-
-
-
Interest and investment income
15.09K
15.09K
-
-
Interest expense
-34.76K
-34.76K
-17.73K
-17.73K
Net interest expenses
-19.67K
-19.67K
-17.73K
-17.73K
Depreciation and amortization charges
40.42K
40.42K
45.23K
45.23K
EBITDA
-1.06M
-1.06M
-1.77M
-1.77M
Gain or loss from assets sale
-
-
-1.52K
-1.52K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps